You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 2
  • CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study

Article metrics

Article menu

Download PDFPDF

Clinical Trials
CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study
Free

 

Online download statistics by month:

Online download statistics by month: September 2018 to August 2024

AbstractFullPdf
Sep 20181802
Oct 20182302
Nov 20181201
Dec 201836012
Jan 201928002
Feb 201937202
Mar 201944603
Apr 201938501
May 201941404
Jun 201939603
Jul 201940201
Aug 201941902
Sep 201935902
Oct 201937103
Nov 201927502
Dec 20193003
Jan 2020600
Feb 2020602
Mar 20202608
Apr 20202608
May 202048024
Jun 20203208
Jul 20203802
Aug 20202002
Sep 20204004
Oct 20202602
Nov 20201201
Dec 20202404
Jan 20211404
Feb 20211203
Mar 20211802
Apr 20213003
May 2021101
Jun 2021106
Jul 2021002
Aug 2021004
Sep 2021004
Oct 202133018
Nov 202130020
Dec 202148010
Jan 20221704
Feb 20221705
Mar 20222203
Apr 20222003
May 202229015
Jun 20221403
Jul 20221601
Aug 20221909
Sep 2022906
Oct 20221607
Nov 20222304
Dec 20221600
Jan 20231107
Feb 2023600
Mar 20231003
Apr 20231401
May 2023601
Jun 20231202
Jul 2023901
Aug 20231304
Sep 2023900
Oct 2023301
Nov 20231102
Dec 20231800
Jan 20241201
Feb 2024800
Mar 20241201
Apr 20242400
May 20241401
Jun 20242002
Jul 20241006
Aug 20241105
Total51800285